Over the 2 months since coronavirus first appeared in China, cases have emerged on every
continent, and it is clear that patients with autoimmune diseases might also be affected …

After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …

Autoimmunity may be a complication of SAR-CoV-2 infection. Understanding the
pathogenesis of autoimmune manifestations in COVID-19 might help prevent the incidence …

The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all
over the world. Reports from China showed that about 20% of patients developed severe …

As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

The outbreak of coronavirus in the world has led to an uncertainty about treatment of
patients with autoimmune disorders because of their weakened immune system coupled …

Background The aim of this review is to explore whether patients with autoimmune diseases
(AIDs) were at high risk of infection during the COVID-19 epidemic and how severe acute …

Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in
overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …

The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …

Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is known that infection with …